U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Acquired by Mason Street Advisors LLC

Mason Street Advisors LLC raised its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,074 shares of the company’s stock after buying an additional 135 shares during the quarter. Mason Street Advisors LLC’s holdings in U.S. Physical Therapy were worth $428,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of USPH. Piedmont Investment Advisors Inc. boosted its holdings in shares of U.S. Physical Therapy by 3.3% in the 4th quarter. Piedmont Investment Advisors Inc. now owns 3,015 shares of the company’s stock worth $309,000 after purchasing an additional 97 shares in the last quarter. Stone Ridge Asset Management LLC boosted its holdings in shares of U.S. Physical Therapy by 2.9% in the 4th quarter. Stone Ridge Asset Management LLC now owns 4,089 shares of the company’s stock worth $419,000 after purchasing an additional 116 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of U.S. Physical Therapy by 3.7% in the 4th quarter. Victory Capital Management Inc. now owns 4,850 shares of the company’s stock worth $496,000 after purchasing an additional 175 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in shares of U.S. Physical Therapy by 3.3% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 6,061 shares of the company’s stock worth $621,000 after purchasing an additional 191 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its holdings in shares of U.S. Physical Therapy by 2.2% in the 4th quarter. Thrivent Financial for Lutherans now owns 9,062 shares of the company’s stock worth $928,000 after purchasing an additional 199 shares in the last quarter. Hedge funds and other institutional investors own 99.58% of the company’s stock.

USPH has been the subject of several analyst reports. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 target price for the company in a report on Friday, April 26th. William Blair began coverage on U.S. Physical Therapy in a research report on Thursday, March 7th. They set an “outperform” rating and a $106.61 price target for the company. TheStreet raised U.S. Physical Therapy from a “c+” rating to a “b” rating in a research report on Friday, March 8th. ValuEngine lowered U.S. Physical Therapy from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, March 6th. Finally, Barrington Research reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a research report on Friday, May 3rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $111.40.

USPH stock traded down $0.95 on Wednesday, reaching $118.39. 97,468 shares of the company traded hands, compared to its average volume of 88,606. U.S. Physical Therapy, Inc. has a one year low of $95.50 and a one year high of $129.65. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.18 and a current ratio of 1.18. The company has a market cap of $1.51 billion, a P/E ratio of 44.68, a P/E/G ratio of 3.61 and a beta of 1.12. The firm’s fifty day simple moving average is $116.69.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, May 2nd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.62 by $0.04. U.S. Physical Therapy had a return on equity of 19.09% and a net margin of 5.34%. The business had revenue of $116.23 million for the quarter, compared to the consensus estimate of $114.12 million. U.S. Physical Therapy’s quarterly revenue was up 7.3% on a year-over-year basis. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.91 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Friday, May 17th were paid a dividend of $0.27 per share. The ex-dividend date was Thursday, May 16th. This represents a $1.08 annualized dividend and a yield of 0.91%. U.S. Physical Therapy’s dividend payout ratio is 40.75%.

In other news, Director Kathleen A. Gilmartin purchased 500 shares of the company’s stock in a transaction dated Friday, March 29th. The shares were purchased at an average cost of $105.17 per share, for a total transaction of $52,585.00. Following the purchase, the director now directly owns 2,500 shares in the company, valued at approximately $262,925. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Mark J. Brookner sold 3,125 shares of the firm’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $115.73, for a total value of $361,656.25. Following the completion of the transaction, the director now owns 33,125 shares in the company, valued at $3,833,556.25. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,735 shares of company stock worth $3,403,083. Company insiders own 2.50% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Story: How Do Tariffs Affect Trade Balances?

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply